Tower Research Capital (TRC)’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $419K | Sell |
|
|||||
|
2025
Q3 | $419K | Buy |
|
|||||
|
2025
Q2 | $30.1K | Sell |
|
|||||
|
2025
Q1 | $82K | Sell |
|
|||||
|
2024
Q4 | $497K | Sell |
|
|||||
|
2024
Q3 | $560K | Sell |
|
|||||
|
2024
Q2 | $787K | Buy |
|
|||||
|
2024
Q1 | $97.2K | Sell |
|
|||||
|
2023
Q4 | $502K | Sell |
|
|||||
|
2023
Q3 | $1.04M | Buy |
|
|||||
|
2023
Q2 | $48.8K | Sell |
|
|||||
|
2023
Q1 | $71K | Sell |
|
|||||
|
2022
Q4 | $546K | Buy |
|
|||||
|
2022
Q3 | $112K | Sell |
|
|||||
|
2022
Q2 | $263K | Buy |
|
|||||
|
2022
Q1 | $229K | Sell |
|
|||||
|
2021
Q4 | $638K | Buy |
|
|||||
|
2021
Q3 | $57K | Sell |
|
|||||
|
2021
Q2 | $1.17M | Buy |
|
|||||
|
2021
Q1 | $195K | Buy |
|
|||||
|
2020
Q4 | $103K | Buy |
|
|||||
|
2020
Q3 | $21K | Buy |
|